GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order HHSN26100012THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

Overview

Award facts

Net obligations
$556.19K
$556,189of $658.2K potential value
Outlays (paid to date)
$86.69K
$86.69K paid of $556.19K obligated$86,692
Period of performance
Sep 1, 2017 to Apr 30, 2022
Ended
Modifications
9
Latest action Dec 13, 2024
Contract type
Delivery order
PIID HHSN26100012

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER

Dates and value

Award date
Signed on Sep 7, 2017
Potential end of performance
Apr 29, 2022
Current value
$556,189Base and exercised options
Potential value (if all options are exercised)
$658,199
Parent contract vehicle
HHSN261201200034I (IDC, multiple award) — 14 orders recorded under it

Obligations by fiscal year of action

  • FY2025: -$17,060 (de-obligation)
  • FY2024: -$16,868 (de-obligation)
  • FY2020: $106,072
  • FY2019: $102,010
  • FY2017: $382,036

Total across 5 fiscal years: $556,189

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 13, 2024. View on USAspending · Recipient on SAM.gov

Recipient

NameTHE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
LocationHOUSTON, TX
UEIS3GMKS8ELA16
CAGE code0KD38
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity
Parent companyTHE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

Business types and certifications

Educational institutionU.S. government entity

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Houston, Harris County, Texas 77030-4017
Congressional district (place of performance)
TX-09As reported at the time of the action

Classification and competition

Classification

NAICS
541712RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product or service (PSC)
AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
1

Contract details

Major program
Cancer prevention agent development program: early phase clinical research
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 7, 2017Base obligation at award: $382,036
Latest action
Dec 13, 2024 — Funding onlyModification P00009; obligation change -$17,060; funding only: changes obligations, not scope
Latest substantive action
Sep 23, 2021 — Change orderModification P00007
Latest funding action
Dec 13, 2024 — Funding onlyModification P00009; obligation change -$17,060; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Change order3
  • Funding only2
  • Option exercised2
  • Other administrative action2
10 actions recorded, Sep 7, 2017 to Dec 13, 2024; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$17,060
Latest action: change in base and all options
-$17,060

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Bio-basedE
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2017/2017-0849-000
  • 075-2019/2019-0849-000
  • 075-2020/2020-0849-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression